OESOPHAGEAL ADENOCARCINOMA STAGE IV

This adverse event was reported 20 times

These drugs are most commonly taken by patients reporting OESOPHAGEAL ADENOCARCINOMA STAGE IV:

# Drug Count
0 OXALIPLATIN 4
1 OMEPRAZOLE MAGNESIUM 3
2 PACLITAXEL 3
3 PACLITAXEL (AIBUMIN-BOUND) 3
4 RAMUCIRUMAB 3
5 ZOLPIDEM TARTRATE 3
6 ALENDRONATE SODIUM 2
7 ALPRAZOLAM 2
8 ERGOCALCIFEROL 2
9 FUROSEMIDE 2
See all common drugs associated with OESOPHAGEAL ADENOCARCINOMA STAGE IV

OESOPHAGEAL ADENOCARCINOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM CHLORIDE 0.65% 1 0.0007
1 RAMUCIRUMAB 3 0.0005
2 ALFUZOSIN HCL 1 0.0003
3 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
4 CLONIDINE HYDROCHLORIDE 1 0.0002
5 HYOSCYAMINE SULFATE 1 0.0001
6 MEPERIDINE HYDROCHLORIDE 1 0.0001
7 NIACIN 1 0.0001
8 SUCRALFATE 2 0.0001
9 INSTALAX POLYETHYLENE GLYCOL 3350 1 0.0001
See all drugs enriched for association with OESOPHAGEAL ADENOCARCINOMA STAGE IV